Kalyan R Chitturi, Sant Kumar, Beni Rai Verma, Waiel Abusnina, Matteo Cellamare, Ilan Merdler, Sevket Tolga Ozturk, Vijoli Cermak, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D Hashim, Brian C Case
{"title":"微血管阻力储备在评估冠状动脉微血管功能障碍中的增量诊断价值。","authors":"Kalyan R Chitturi, Sant Kumar, Beni Rai Verma, Waiel Abusnina, Matteo Cellamare, Ilan Merdler, Sevket Tolga Ozturk, Vijoli Cermak, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D Hashim, Brian C Case","doi":"10.1016/j.carrev.2025.06.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with coronary microvascular dysfunction (CMD) are at increased risk of major adverse cardiovascular events. The index of microcirculatory resistance (IMR) is more specific than coronary flow reserve (CFR) for CMD diagnosis, but the microvascular resistance reserve (MRR) shows potential due to its hemodynamic adjustments. Our study evaluated the diagnostic utility of IMR, MRR, and their combination in CMD diagnosis for patients experiencing angina and non-obstructive coronary arteries (ANOCA).</p><p><strong>Methods: </strong>This observational study analyzed data from the Coronary Microvascular Disease Registry (CMDR) of ANOCA patients at two tertiary care centers from 2021 to 2024. Demographics, lab results, and microvascular testing outcomes using bolus thermodilution were evaluated. Participants were grouped by MRR and IMR levels to evaluate CMD prevalence.</p><p><strong>Results: </strong>Between December 3, 2021, and July 31, 2024, 279 patients with ANOCA underwent invasive microvascular function assessment. Most were female (67.4 %), with an average age of 61.6 ± 11.0 years. CMD prevalence varied by group: 100 % in low MRR/high IMR, 92.3 % in high MRR/high IMR, 13.9 % in low MRR/low IMR, and 2.8 % in high MRR/low IMR (P < 0.001). IMR showed high diagnostic accuracy (81.6 % sensitivity, 99.5 % specificity), while MRR had 79 % sensitivity and 69.5 % specificity. Combining high IMR and low MRR improved specificity to 100 % but reduced sensitivity (65.8 %). ROC analysis showed AUCs of 0.80 (MRR), 0.97 (IMR), and 0.98 (IMR + MRR).</p><p><strong>Conclusions: </strong>The combination of IMR and MRR enhanced diagnostic specificity for CMD in patients with ANOCA, highlighting their complementary value. Future studies should focus on larger cohorts to validate these findings.</p>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The incremental diagnostic value of microvascular resistance reserve in the assessment of coronary microvascular dysfunction.\",\"authors\":\"Kalyan R Chitturi, Sant Kumar, Beni Rai Verma, Waiel Abusnina, Matteo Cellamare, Ilan Merdler, Sevket Tolga Ozturk, Vijoli Cermak, Vaishnavi Sawant, Itsik Ben-Dor, Ron Waksman, Hayder D Hashim, Brian C Case\",\"doi\":\"10.1016/j.carrev.2025.06.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Patients with coronary microvascular dysfunction (CMD) are at increased risk of major adverse cardiovascular events. The index of microcirculatory resistance (IMR) is more specific than coronary flow reserve (CFR) for CMD diagnosis, but the microvascular resistance reserve (MRR) shows potential due to its hemodynamic adjustments. Our study evaluated the diagnostic utility of IMR, MRR, and their combination in CMD diagnosis for patients experiencing angina and non-obstructive coronary arteries (ANOCA).</p><p><strong>Methods: </strong>This observational study analyzed data from the Coronary Microvascular Disease Registry (CMDR) of ANOCA patients at two tertiary care centers from 2021 to 2024. Demographics, lab results, and microvascular testing outcomes using bolus thermodilution were evaluated. Participants were grouped by MRR and IMR levels to evaluate CMD prevalence.</p><p><strong>Results: </strong>Between December 3, 2021, and July 31, 2024, 279 patients with ANOCA underwent invasive microvascular function assessment. Most were female (67.4 %), with an average age of 61.6 ± 11.0 years. CMD prevalence varied by group: 100 % in low MRR/high IMR, 92.3 % in high MRR/high IMR, 13.9 % in low MRR/low IMR, and 2.8 % in high MRR/low IMR (P < 0.001). IMR showed high diagnostic accuracy (81.6 % sensitivity, 99.5 % specificity), while MRR had 79 % sensitivity and 69.5 % specificity. Combining high IMR and low MRR improved specificity to 100 % but reduced sensitivity (65.8 %). ROC analysis showed AUCs of 0.80 (MRR), 0.97 (IMR), and 0.98 (IMR + MRR).</p><p><strong>Conclusions: </strong>The combination of IMR and MRR enhanced diagnostic specificity for CMD in patients with ANOCA, highlighting their complementary value. Future studies should focus on larger cohorts to validate these findings.</p>\",\"PeriodicalId\":47657,\"journal\":{\"name\":\"Cardiovascular Revascularization Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Revascularization Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.carrev.2025.06.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.carrev.2025.06.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
The incremental diagnostic value of microvascular resistance reserve in the assessment of coronary microvascular dysfunction.
Background: Patients with coronary microvascular dysfunction (CMD) are at increased risk of major adverse cardiovascular events. The index of microcirculatory resistance (IMR) is more specific than coronary flow reserve (CFR) for CMD diagnosis, but the microvascular resistance reserve (MRR) shows potential due to its hemodynamic adjustments. Our study evaluated the diagnostic utility of IMR, MRR, and their combination in CMD diagnosis for patients experiencing angina and non-obstructive coronary arteries (ANOCA).
Methods: This observational study analyzed data from the Coronary Microvascular Disease Registry (CMDR) of ANOCA patients at two tertiary care centers from 2021 to 2024. Demographics, lab results, and microvascular testing outcomes using bolus thermodilution were evaluated. Participants were grouped by MRR and IMR levels to evaluate CMD prevalence.
Results: Between December 3, 2021, and July 31, 2024, 279 patients with ANOCA underwent invasive microvascular function assessment. Most were female (67.4 %), with an average age of 61.6 ± 11.0 years. CMD prevalence varied by group: 100 % in low MRR/high IMR, 92.3 % in high MRR/high IMR, 13.9 % in low MRR/low IMR, and 2.8 % in high MRR/low IMR (P < 0.001). IMR showed high diagnostic accuracy (81.6 % sensitivity, 99.5 % specificity), while MRR had 79 % sensitivity and 69.5 % specificity. Combining high IMR and low MRR improved specificity to 100 % but reduced sensitivity (65.8 %). ROC analysis showed AUCs of 0.80 (MRR), 0.97 (IMR), and 0.98 (IMR + MRR).
Conclusions: The combination of IMR and MRR enhanced diagnostic specificity for CMD in patients with ANOCA, highlighting their complementary value. Future studies should focus on larger cohorts to validate these findings.
期刊介绍:
Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.